Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00663793 · ClinicalTrials.gov registry record · Phase 1
ORAL T-6: Oral Androgens in Man-6
A Phase 1 study of Contraception and Hypogonadism, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT00663793 is a Phase 1 study of Contraception and Hypogonadism that has completed, run by University of Washington. The registered enrollment target is 16 participants, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00663793, a Phase 1 study of Contraception and Hypogonadism, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
We propose a study to determine the single-dose pharmacokinetics of these two novel formulations of testosterone in normal men with experimentally induced hypogonadism.
Conditions Studied
Interventions
- DRUG Finasteride
- DRUG Testosterone
- DRUG Acyline
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00663793
The ClinicalTrials.gov registry entry for NCT00663793 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 454-participant average among 72 other Contraception trials with a reported enrollment target (96% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Contraception appearing as the primary indexed condition, and to 3 interventions - of which Finasteride is the first listed.
NCT00663793 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00663793 about?
NCT00663793 is a clinical study titled "ORAL T-6: Oral Androgens in Man-6". We propose a study to determine the single-dose pharmacokinetics of these two novel formulations of testosterone in normal men with experimentally induced hypogonadism.
What is the current status of trial NCT00663793?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2008-10. Estimated completion is 2009-06.
What conditions does trial NCT00663793 study?
This clinical trial studies the following conditions: Contraception, Hypogonadism.
What interventions are being tested in trial NCT00663793?
The interventions under investigation include: Finasteride (DRUG), Testosterone (DRUG), Acyline (DRUG).
Who is sponsoring clinical trial NCT00663793?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00663793 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacokinetic and Pharmacodynamic Study of Cyclofem
COMPLETED · Phase 1
-
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
COMPLETED · Phase 1
-
NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel
COMPLETED · Phase 1
-
A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age
COMPLETED · Phase 1
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.